Conforms to 93/112/EC and ISO 11014-1
Material Safety Data Sheet
Surfact-Amps 35
2437
0028316 0028316B
CALL CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
11/4/2002
11/14/2002
Product name
Supplier
Manufacturer
Product No.
MSDS#
Validation Date
Print Date
In Case of Emergency
Section 1. Chemical Product and Company Identification
Responsible Name Pierce Administration
Intended Use Refer to the instruction booklet for proper and intended use. Otherwise, contact supplier for specific applications.
Eng
In USA:
In Europe:
Pierce
Perbio Science
P.O. Box 117
Industriezone III
Rockford, IL 61105 Industrielaan 27
USA
9320 Erembodegem-Aalst
815.968.0747 or
Belgium
1.800.874.3723
Tel:+32 53 83 44 04
Fax:+32 53 83 76 38
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
USA
815.968.0747 or
1.800.874.3723
No hazardous ingredient according to 29 CFR 1910.1200 Hazard Communication Standard (USA) and Directives 1999/45/EC-2001/59/EC (EU)
Ingredient Name
EC Number
CAS No.
R-Phrases
Substance/Preparation
Preparation
%
Symbol
:
Section 2. Composition, Information on Ingredients
Physical/chemical hazards
Human health hazards
Environmental hazards Not applicable.
Not applicable.
Not applicable.
Absorbed through skin. Eye contact. Inhalation. Ingestion.
Emergency Overview
Medical Conditions Aggravated
by Overexposure:
Repeated or prolonged exposure is not known to aggravate medical condition.
Not available.
Overexposure /Signs/Symptoms
Section 3. Hazards Identification
Routes of Entry
Potential Acute Health Effects
Carcinogenic Effects Data
See Toxicological Information (section 11)
Slightly hazardous in case of skin contact (irritant), of eye contact (irritant). Non-hazardous in case of ingestion.
Non-hazardous in case of inhalation. Non-irritant for lungs.
CARCINOGENIC EFFECTS: Classified None. by NIOSH [Brij 35].
MUTAGENIC EFFECTS: Not available.
TERATOGENIC EFFECTS: Not available.
Review the most current and approved institutional guideline, protocol, standard operating procedure(s) and MSDS(s)
for the prope